Hull & East Riding Fertility

Hull & East Riding Fertility has over three decades of experience providing a comprehensive range of fertility investigations and treatments. Success rates for clinical pregnancies per embryo transfer cycle are reported as follows—women under age 35 have a rate of approximately 44.8%, ages 35–39 at 29.1%, age 40+ at 12.5%, with an overall average across all ages at 37.1%.[3] The clinic offers both NHS-funded and private care with no waiting lists. Treatments include IVF, ICSI, surgical sperm recovery, egg/sperm/embryo freezing, use of donor gametes or surrogacy arrangements, fertility preservation for oncology patients, counselling services included in treatment costs,[6] and satellite clinics to improve access in the region.[8] The company recruits UK-based egg/sperm donors for both clinical use and research projects.[4] There are no investigational drugs or traditional biotech/pharma pipelines; the focus is on established ART procedures. Clinical results are consistent with national averages; detailed HFEA data will be updated after system upgrades in late 2025.[4] No evidence was found that the company has been acquired or merged. No public trading symbol exists; this remains a privately held entity. Key people include named responsible clinicians but not widely publicized online. Main location is Hesslewood Business Park near Hull; satellite presence in York via partnership with Yorkshire Sports Medicine.[8]